Sign In
Buy ABBV
$217.07
+1.64 (+0.761%)
At Close: Jun 03, 2026
Here's How Many Shares of AbbVie (ABBV) Stock You'd Need for $10,000 in Yearly Dividends
05:46am, Friday, 27'th Mar 2026
AbbVie has increased its dividend by more than 330% since 2013. It has a robust pipeline of drugs in development and growing revenue, too.
Czech National Bank Purchases 17,373 Shares of AbbVie Inc. $ABBV
04:43am, Thursday, 26'th Mar 2026
Czech National Bank raised its position in shares of AbbVie Inc. (NYSE: ABBV) by 3.9% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exch
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
10:01am, Wednesday, 25'th Mar 2026
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
LLY or ABBV: Which Drugmaker is Likely to Offer Better Upside in 2026?
09:56am, Wednesday, 25'th Mar 2026
LLY's obesity drugs fuel explosive growth, while ABBV depends on Skyrizi and Rinvoq. Let's see which drugmaker has the stronger 2026 outlook.
5,856 Shares in AbbVie Inc. $ABBV Acquired by Clear Trail Advisors LLC
04:14pm, Tuesday, 24'th Mar 2026
Clear Trail Advisors LLC bought a new position in AbbVie Inc. (NYSE: ABBV) during the undefined quarter, according to its most recent filing with the SEC. The institutional investor bought 5,856 share
AbbVie Inc. $ABBV is BDF Gestion’s 10th Largest Position
03:04pm, Tuesday, 24'th Mar 2026
BDF Gestion grew its holdings in AbbVie Inc. (NYSE: ABBV) by 28.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fi
Protagonist Partners With Johnson & Johnson To Compete With AbbVie's Skyrizi
08:45am, Tuesday, 24'th Mar 2026
Protagonist Therapeutics earns a Buy rating, driven by Icotyde's FDA approval and robust near-term commercialization catalysts. Icotyde, the first oral IL-23 receptor antagonist for plaque psoriasis,
AbbVie Named Official Pharmaceutical Partner of Major League Baseball
08:00am, Tuesday, 24'th Mar 2026
Partnership expands "Striking Out Cancer" campaign beginning on Opening Day AbbVie named Official Pharmaceutical Partner of Major League Baseball (MLB), expanding Striking Out Cancer league-wide start
What Is Considered a Good Stock Dividend? 2 Healthcare Stocks Fit the Bill.
07:06am, Tuesday, 24'th Mar 2026
Both companies have distributions boasting above-average yields. One is even a Dividend King.
Why AbbVie Stock Looks Like a Dirt Cheap Buy Right Now
02:30pm, Monday, 23'rd Mar 2026
AbbVie's growth rate has been accelerating in recent quarters. Its diverse business can enable it to continue growing at a strong rate in the future.
AbbVie Inc. $ABBV Stake Reduced by Gradient Investments LLC
07:00am, Monday, 23'rd Mar 2026
Gradient Investments LLC trimmed its holdings in AbbVie Inc. (NYSE: ABBV) by 7.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund o
AbbVie Inc. $ABBV Shares Sold by Fulton Bank N.A.
06:27am, Monday, 23'rd Mar 2026
Fulton Bank N.A. cut its stake in shares of AbbVie Inc. (NYSE: ABBV) by 5.8% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4
Nordea Investment Management AB Has $950.63 Million Holdings in AbbVie Inc. $ABBV
05:48am, Monday, 23'rd Mar 2026
Nordea Investment Management AB decreased its position in shares of AbbVie Inc. (NYSE: ABBV) by 7.7% in the undefined quarter, according to the company in its most recent Form 13F filing with the Secu
US FDA flags seizure risk with certain Parkinson's drugs, seeks label warnings
12:11pm, Friday, 20'th Mar 2026
The U.S. Food and Drug Administration said on Friday it has notified manufacturers of certain Parkinson's disease treatments to update their prescribing information with a new warning about a po
Best Healthcare Stocks to Buy After the Market Pullback
07:15am, Friday, 20'th Mar 2026
CVS Health's diversified business can help it overcome recent challenges. AbbVie's two most important medicines are performing extremely well.
